Odyssey Therapeutics, Inc. (NASDAQ:ODTX – Get Free Report) was the target of a large increase in short interest in the month of May. As of May 15th, there was short interest totaling 86,503 shares, an increase of ∞ from the April 30th total of 0 shares. Based on an average daily volume of 426,652 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.2% of the shares of the stock are sold short.
Odyssey Therapeutics Price Performance
Shares of NASDAQ ODTX traded down $0.05 during trading hours on Monday, reaching $16.96. 127,382 shares of the stock traded hands, compared to its average volume of 330,139. Odyssey Therapeutics has a 52-week low of $15.35 and a 52-week high of $20.30.
Insiders Place Their Bets
In related news, major shareholder Sr One Capital Management, Llc bought 555,555 shares of the business’s stock in a transaction on Monday, May 11th. The stock was acquired at an average price of $18.00 per share, for a total transaction of $9,999,990.00. Following the purchase, the insider directly owned 1,831,383 shares in the company, valued at $32,964,894. This trade represents a 43.54% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Tpg Gp A, Llc bought 1,388,889 shares of the business’s stock in a transaction on Monday, May 11th. The stock was bought at an average price of $18.00 per share, with a total value of $25,000,002.00. Following the purchase, the insider owned 3,690,146 shares in the company, valued at $66,422,628. This trade represents a 60.35% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have purchased 4,183,777 shares of company stock worth $75,319,986 over the last quarter.
Wall Street Analyst Weigh In
Check Out Our Latest Analysis on ODTX
Recommended Stories
- Five stocks we like better than Odyssey Therapeutics
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Odyssey Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Odyssey Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
